Comprehensive Integration of Treatments and Therapies for Esophageal Cancer

Shijun Zheng

2025

Abstract

Esophageal cancer is one of the most deadly malignant tumors worldwide, with high mortality and few therapeutic options. It ranks as the eighth most prevalent cancer globally and the sixth largest factor of common cancer-related death. Epigenetics is of great interest in the adenocarcinoma stage of its development and undergoing intense investigation as a field for potential translation towards both research and therapy of esophageal cancer. This focus highlights a methylation of RNA and an epigenetic alteration of N6-methyladenosine (m6A). Another significant mechanism associated with esophageal cancer is DNA methylation. Esophageal cancer frequently results in abnormal DNA methylation events, such as hypomethylation of oncogenes and hypermethylation of tumor suppressor genes. The impact of nutrition on esophageal cancer both before and after therapy has been studied, much like the previously described treatment approaches. However, the most cutting-edge approach to cancer treatment is the use of nanomaterials, which offer therapeutic chemicals or target-specific therapy.

Paper Citation

in Harvard Style

Zheng S. (2025). Comprehensive Integration of Treatments and Therapies for Esophageal Cancer. In Proceedings of the 1st International Conference on Biomedical Engineering and Food Science - Volume 1: BEFS; ISBN 978-989-758-789-4, SciTePress, pages 287-294. DOI: 10.5220/0014486800004933

in Bibtex Style

@conference{befs25,
author={Shijun Zheng},
title={Comprehensive Integration of Treatments and Therapies for Esophageal Cancer},
booktitle={Proceedings of the 1st International Conference on Biomedical Engineering and Food Science - Volume 1: BEFS},
year={2025},
pages={287-294},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0014486800004933},
isbn={978-989-758-789-4},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 1st International Conference on Biomedical Engineering and Food Science - Volume 1: BEFS
TI - Comprehensive Integration of Treatments and Therapies for Esophageal Cancer
SN - 978-989-758-789-4
AU - Zheng S.
PY - 2025
SP - 287
EP - 294
DO - 10.5220/0014486800004933
PB - SciTePress